Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carrillo

Showing results (381-390 of 522) with videos related to

Pageof 53
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 8, 2016
Tau: From research to clinical developmentDavid M Holtzman, Maria C Carrillo, James A Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Research and standardization in Alzheimer's trials: reaching international consensusMaria C Carrillo, Christopher C Rowe, Cassandra Szoeke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2011
Revision of the criteria for Alzheimer’s disease: A symposiumSteven T DeKosky, Maria C Carrillo, Creighton Phelps, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Identification of patients receiving amyloid-targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADSRenaud La Joie, Ganna Blazhenets, Piyush Maiti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB)Enchi Liu, Johan Luthman, Jesse M Cedarbaum, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug developmentGil D Rabinovici, Maria C Carrillo, Mark Forman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
The roles of inflammation and immune mechanisms in Alzheimer's diseaseLinda J Van Eldik, Maria C Carrillo, Patricia E Cole, et al.
JAMA Neurology|October 3, 2022
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort StudyConsuelo H Wilkins, Charles C Windon, Peggye Dilworth-Anderson, et al.
Journal of Virology|September 21, 2018
Molecular Characterization of the Viroporin Function of Foot-and-Mouth Disease Virus Nonstructural Protein 2BD P Gladue, E Largo, I de la Arada, et al.
Pageof 53

Showing results (381-390 of 522) with videos related to

Sort By:
Pageof 53
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 8, 2016
Tau: From research to clinical developmentDavid M Holtzman, Maria C Carrillo, James A Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Research and standardization in Alzheimer's trials: reaching international consensusMaria C Carrillo, Christopher C Rowe, Cassandra Szoeke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2011
Revision of the criteria for Alzheimer’s disease: A symposiumSteven T DeKosky, Maria C Carrillo, Creighton Phelps, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Identification of patients receiving amyloid-targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADSRenaud La Joie, Ganna Blazhenets, Piyush Maiti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB)Enchi Liu, Johan Luthman, Jesse M Cedarbaum, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug developmentGil D Rabinovici, Maria C Carrillo, Mark Forman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
The roles of inflammation and immune mechanisms in Alzheimer's diseaseLinda J Van Eldik, Maria C Carrillo, Patricia E Cole, et al.
JAMA Neurology|October 3, 2022
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort StudyConsuelo H Wilkins, Charles C Windon, Peggye Dilworth-Anderson, et al.
Journal of Virology|September 21, 2018
Molecular Characterization of the Viroporin Function of Foot-and-Mouth Disease Virus Nonstructural Protein 2BD P Gladue, E Largo, I de la Arada, et al.
Pageof 53